Latest Rituximab Stories

2012-07-23 06:17:28

(Ivanhoe Newswire) - Each year an estimated 70,000 people globally are diagnosed with the kidney immune disorder, idiopathic membranous nephropathy (IMN). Idiopathic membranous nephropathy (IMN) can eventually lead to kidney failure. Standard therapies for IMN can be toxic and lead to further complications, but a new study has discovered the drug rituximab which is commonly used to treat lymphoma and arthritis also benefits patients with IMN. Standard therapy for IMN includes...

2012-07-20 12:07:36

Rituximab is more effective and less toxic than standard therapies Highlights: Patients with a particular kidney immune disorder experienced remission when taking the immune drug rituximab, even when standard therapies had failed. Rituximab was safe and well-tolerated by all patients in the study. Each year, an estimated 70,000 people globally are diagnosed with the disorder, called idiopathic membranous nephropathy. A drug commonly used to treat immune disorders such as lymphoma...

2012-06-07 11:58:43

Results of a separate study demonstrate that early and sustained remission are associated with decrease mortality According to a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, patients with rheumatoid arthritis (RA) who are prescribed biologic treatments have a significantly lower mortality risk (adjusted hazard ratio [HR]: 0.61) than those just treated with traditional disease modifying anti-rheumatic drugs (DMARDs). The study also...

Word of the Day
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.